Medplus Health Services credit ratios

·Consumer ServicesChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
−462−462−367−142−284
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−0.23×−0.23×−0.21×−0.09×−0.19×
−0.73×−0.76×−0.75×−0.40×−1.07×
2.69×2.69×2.31×1.35×1.01×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MEDPLUS₹598.05

Medplus Health Services Ltd.

· Consumer Services
₹ CrorePeersAPOLLOHOSPMANYAVARMSTCLTDNESCOJUSTDIALJSLLQUESSIXIGOMcap ₹7,180 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Net Debt-283.9-141.7-367.2-462.2-462.2
Net Debt/Equity-0.19-0.09-0.21-0.23-0.23
Net Debt/EBITDA-1.07-0.40-0.75-0.76-0.73
Interest Coverage (EBIT/Interest)1.011.352.312.692.69
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.